miRNA-182/Deptor/mTOR axis regulates autophagy to reduce intestinal ischaemia/reperfusion injury

Yunsheng Li1, Yanhua Luo2, Baochuan Li1

  • 1Department of Anesthesiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Insights

Upregulating miR-182 reduces intestinal ischemia/reperfusion (I/R) injury by inhibiting autophagy via the mTOR pathway, targeting Deptor. This finding offers a potential therapeutic strategy for I/R damage.

Area of Science:

  • Gastroenterology
  • Molecular Biology
  • Immunology

Background:

  • Intestinal ischemia/reperfusion (I/R) injury is a significant clinical challenge.
  • MicroRNA-182 (miR-182) is reportedly downregulated following intestinal I/R, but its role remains unclear.

Purpose of the Study:

  • To investigate the function of miR-182 in intestinal I/R injury.
  • To elucidate the underlying molecular mechanisms involving Deptor and autophagy.

Main Methods:

  • Intestinal I/R injury models in wild-type and Deptor knockout mice.
  • Histopathological analysis (H&E staining, Chiu's score), biochemical assays (diamine oxidase).
  • Molecular analyses including RT-qPCR, Western blot, and dual-luciferase reporter assay.

Main Results:

  • miR-182 expression was decreased in intestinal I/R.
  • Upregulation of miR-182 ameliorated I/R-induced damage, reduced autophagy, decreased Deptor levels, and enhanced mTOR activity.
  • Deptor was identified as a direct target of miR-182, crucial for its protective effects.

Conclusions:

  • miR-182 plays a protective role against intestinal I/R injury.
  • miR-182 alleviates I/R damage by inhibiting autophagy through the mTOR pathway via targeting Deptor.
  • Targeting miR-182 represents a potential therapeutic avenue for intestinal I/R injury.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K